e-Drug3D 1170 |
NIMODIPINE
|
cas 66085-59-4 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters F 13 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET CALCIUM CHANNEL |
DrugCentral Voltage-dependent L-type calcium channel subunit alpha-1C UNIPROT Q13936 CACNA1C Voltage-dependent L-type calcium channel subunit alpha-1D UNIPROT Q01668 CACNA1D |
Download SDF file | O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Formula: Calculated chemical properties: MW 418.44 NB_atoms 30 XLogP 0 PSA 106.51 NB_HD 1 NB_HA 8 fsp3 0.43 Lipinski(0=no;1=yes) 1 |
FDA NDA 018869 (label) INN (NIMODIPINE) NIMOTOP (BAYER PHARMS) APPROVAL= AP YEAR= 1988 DISCONTINUED NDA 077067 (pdf not found) INN (NIMODIPINE) NIMODIPINE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 077811 (pdf not found) INN (NIMODIPINE) NIMODIPINE (HERITAGE) APPROVAL= AP YEAR= 2007 NDA 076740 (pdf not found) INN (NIMODIPINE) NIMODIPINE (BIONPHARMA) APPROVAL= AP YEAR= 2008 NDA 203340 (label) INN (NIMODIPINE) NYMALIZE (AZURITY) APPROVAL= AP YEAR= 2013 NDA 090103 (pdf not found) INN (NIMODIPINE) NIMODIPINE (THEPHARMANETWORK LLC) APPROVAL= AP YEAR= 2014 NDA 201832 (pdf not found) INN (NIMODIPINE) NIMODIPINE (SOFGEN PHARMS) APPROVAL= AP YEAR= 2015 DISCONTINUED NDA 216937 (pdf not found) INN (NIMODIPINE) NIMODIPINE (ANNORA PHARMA) APPROVAL= AP YEAR= 2024 NDA 213409 (pdf not found) INN (NIMODIPINE) NIMODIPINE (ALKEM LABS LTD) APPROVAL= AP YEAR= 2025 |
Other links: |